Median 4‐year outcomes of salvage irreversible electroporation for localized radio‐recurrent prostate cancer

B Geboers, MJ Scheltema, A Blazevski… - BJU …, 2023 - Wiley Online Library
Objectives To evaluate the safety, and short to mid‐term oncological and quality‐of‐life
(QoL) outcomes of focal irreversible electroporation (IRE) for radio‐recurrent prostate cancer …

Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio‐recurrent prostate cancer

MJ Scheltema, W van den Bos… - BJU …, 2017 - Wiley Online Library
Objectives To evaluate the feasibility, safety, early quality‐of‐life (QoL) and oncological
outcomes of salvage focal irreversible electroporation (IRE) for radio‐recurrent prostate …

Salvage irreversible electroporation for radio‐recurrent prostate cancer–the prospective FIRE trial

A Blazevski, B Geboers, MJ Scheltema… - BJU …, 2023 - Wiley Online Library
Objectives To prospectively assess the safety, functional‐and oncological‐outcomes of
irreversible electroporation (IRE) as salvage therapy for radio‐recurrent focal prostate …

Median 5‐year outcomes of primary focal irreversible electroporation for localised prostate cancer

MJ Scheltema, B Geboers, A Blazevski… - BJU …, 2023 - Wiley Online Library
Objectives To evaluate longer‐term oncological and functional outcomes of focal irreversible
electroporation (IRE) as primary treatment for localised clinically significant prostate cancer …

Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer

LA van Riel, B Geboers, E Kabaktepe… - BJU …, 2022 - Wiley Online Library
Objective To evaluate:(i) safety,(ii) feasibility, and medium‐term (iii) oncological and (iv)
functional outcomes of salvage radical prostatectomy (sRP) for recurrent localised prostate …

[HTML][HTML] Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study

WJ Yaxley, T Gianduzzo, B Kua, R Oxford… - … and clinical urology, 2022 - ncbi.nlm.nih.gov
Purpose Focal irreversible electroporation (IRE) for prostate cancer aims to reduce quality of
life complications, however outcomes data remains limited. We aimed to evaluate …

Focal irreversible electroporation as primary treatment for localized prostate cancer

W van den Bos, MJ Scheltema… - BJU …, 2018 - Wiley Online Library
Objectives To determine the safety, quality of life (QoL) and short‐term oncological
outcomes of primary focal irreversible electroporation (IRE) for the treatment of localized …

Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective …

A Blazevski, MJ Scheltema, B Yuen, N Masand… - European urology …, 2020 - Elsevier
Background Focal irreversible electroporation (IRE) can be used to treat men with localised
prostate cancer (PCa) with reduced impact on quality of life (QoL). Objective To assess …

Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control

F Ting, M Tran, M Böhm, A Siriwardana… - Prostate cancer and …, 2016 - nature.com
Background: Current data on the use of irreversible electroporation (IRE) in the treatment of
prostate cancer (PCa) is limited. We aim to evaluate the safety, short-term functional and …

Focal Irreversible Electroporation for Localized Prostate Cancer–Oncological and Safety Outcomes Using mpMRI and Transperineal Biopsy Follow-Up

I Gielchinsky, N Lev-Cohain - Research and Reports in Urology, 2023 - Taylor & Francis
Introduction Irreversible electroporation (IRE) technology for prostate cancer (PC) generates
consecutive electrical pulses between pairs of electrodes which move through tumorous …